Phase III Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Trial of Gefitinib versus Placebo in Esophageal Cancer Progressing after Chemotherapy, COG (Cancer Oesophagus Gefitinib)
D. Ferry(Gifu University Hospital), S.J. Dutton(Nihon University), Wasat Mansoor(Kitasato University East Hospital), J N Thompson(Cancer Services), M. Harrison(Mount Vernon Cancer Centre), Hanem Abbas(Gifu University Hospital), Åsa Dahle-Smith(Kitasato University), Anindya Chatterjee(Royal Shrewsbury Hospital), Stephen Falk(At Bristol), Angel Garcia-Alonso(Glan Clwyd Hospital), D. Fyfe(Royal Lancaster Infirmary), Richard Hubner(Kitasato University East Hospital), Tina Gamble(Heartlands Hospital), Lynnda Peachey(Nihon University), Mina Davoudianfar(Nihon University), Sarah Pearson(University of Oxford), Patrick Julier(Nihon University), J Jankowski(Centre For Digestive Diseases), Rachel Midgely(University of Oxford), Robert Petty(University of Aberdeen)
Cited by 16
Abstract
Related Papers
No related papers found
Powered by citation graph analysis